Allspring Global Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-94,682
Closed -$1.25M – 1775
2025
Q1
$1.25M Sell
94,682
-439,622
-82% -$6.07M ﹤0.01% 1200
2024
Q4
$8.37M Buy
534,304
+649
+0.1% +$9.75K 0.01% 817
2024
Q3
$8.48M Buy
533,655
+87,355
+20% +$1.41M 0.01% 820
2024
Q2
$6.8M Sell
446,300
-96,190
-18% -$1.38M 0.01% 871
2024
Q1
$7.96M Sell
542,490
-35,005
-6% -$511K 0.01% 827
2023
Q4
$8.04M Buy
577,495
+47,070
+9% +$629K 0.01% 812
2023
Q3
$7.09M Sell
530,425
-10,410
-2% -$141K 0.01% 852
2023
Q2
$6.83M Sell
540,835
-1,405
-0.3% -$16.4K 0.01% 904
2023
Q1
$6.17M Buy
542,240
+130,030
+32% +$1.4M 0.01% 943
2022
Q4
$4.27M Sell
412,210
-140,585
-25% -$1.52M 0.01% 1030
2022
Q3
$5.79M Sell
552,795
-96,620
-15% -$1.03M 0.01% 938
2022
Q2
$7.19M Buy
649,415
+229,885
+55% +$2.5M 0.01% 881
2022
Q1
$4.68M Sell
419,530
-12,040
-3% -$137K 0.01% 1171
2021
Q4
$5.64M Buy
+431,570
New +$5.44M 0.01% 1136

Other funds holding RDY

Allspring Global Investments's RDY Position: Q2 2025 in Review

Allspring Global Investments sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 94,682 shares — an estimated $1.25M sold.

Allspring Global Investments first reported a position in RDY in Q4 2021 and held it in 14 quarters. The position peaked at $8.48M in Q3 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • Allspring Global Investments reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 94,682 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $1.25M.
  • Allspring Global Investments first reported a position in Dr. Reddy's Laboratories in Q4 2021 and held it in 14 quarters.
  • Allspring Global Investments's Dr. Reddy's Laboratories position peaked at $8.48M in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.